Historical perspectives and the future of adverse reactions associated with haemopoietic stem cells cryopreserved with dimethyl sulfoxide

Cell and Tissue Banking

Volumn 13, Issue 2, 2012, Pages 203-215

  Cox, Michael A ^a   Kastrup, Jens ^b   Hrubiško, Mikulas ^c  

^a DANISH MEDICINES AGENCY   (Denmark)

^b Mental Health Center Glostrup   (Denmark)

^c SLOVAK MEDICAL UNIVERSITY   (Slovakia)

Author keywords

Adverse reactions; Dimethyl sulfoxide; Stem cells; Toxicity; Transplantation

Indexed keywords

CRYOPROTECTIVE AGENT; DIMETHYL SULFOXIDE;

CRYOPRESERVATION; CYTOLOGY; EUROPE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTORY; HUMAN; INSTRUMENTATION; LEGAL ASPECT; METHODOLOGY; REVIEW;

CRYOPRESERVATION; CRYOPROTECTIVE AGENTS; DIMETHYL SULFOXIDE; EUROPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HISTORY, 20TH CENTURY; HUMANS;

EID: 84861528811     PISSN: 13899333     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10561-011-9248-2     Document Type: Review

References (87)

1. Abdelkefi A, Lakhal A, Moojat N, Hamed LB, Fekih J, Ladeb S, Torjman L, Benothman T (2009) Severe neurotoxicity associated with dimethyl sulphoxide following PBSCT. Bone Marrow Transplant 44 (5): 323-324
2. Abrahamsen JF, Bakken AM, Bruserud O (2002) Cryopreserving human peripheral blood progenitor cells with 5% rather than 10% DMSO results in less apoptosis and necrosis in CD34? cells. Transfusion 42 (12): 1573-1580
3. Abrahamsen JF, Rusten L, Bakken AM, Bruserud O (2004) Better preservation of early hematopoietic progenitor cells when human peripheral blood progenitor cells are cryopreserved with 5% dimethylsulfoxide instead of 10% dimethylsulfoxide. Transfusion 44 (5): 785-789 (Pubitemid 38608259)
4. Ademokun JA, Chapman C, Dunn J, Lander D, Mair K, Proctor SJ et al (1997) Umbilical cord blood collection and separation for haematopoietic progenitor cell banking. Bone Marrow Transplant 19 (10): 1023-1028 (Pubitemid 27232179)
5. Adorno G, Bruno A, Caravita T, Venditti A, Ballatore G, Santinelli S et al (1998) Red blood cell depletion of cord blood using hydroxyethylstarch double sedimentation: analysis of 40 cases. Clin Lab Haematol 20 (6): 341-343 (Pubitemid 29030239)
6. Akkok CA, Liseth K, Nesthus I, Lokeland T, Tefre K, Bruserud O et al (2008) Autologous peripheral blood progenitor cells cryopreserved with 5 and 10% dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation. Transfusion 48 (5): 877-883 (Pubitemid 351614914)
7. Akkok CA, Liseth K, Hervig T, Ryningen A, Bruserud O, Ersvaer E (2009) Use of different DMSO concentrations for cryopreservation of autologous peripheral blood stem cell grafts does not have any major impact on levels of leukocyte and platelet-derived soluble mediators. Cytotherapy 11 (6): 749-760
8. Alessandrino P, Bernasconi P, Caldera D, Colombo A, Bonfichi M, Malcovati L et al (1999) Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. Bone Marrow Transplant 23 (6): 533-537 (Pubitemid 29137440)
9. Angelini A, Iacone A, Dragani A, Accorsi P, D'Antonio D, Geraci L et al (1988) Enrichment of marrow haemopoietic progenitor cells using a blood cell processor. Int J Artif Organs 11 (1): 57-60 (Pubitemid 18070438)
10. Ayello J, Hesdorffer C, Reiss RF (1995) A semi automated technique for volume reduction of stem cell suspensions for transplantation. J Hematother 4: 545-549 (Pubitemid 26020558)
11. Bakken AM, Bruserud O, Abrahamsen JF (2003) No differences in colony formation of peripheral blood stem cells frozen with 5 or 10% dimethyl sulfoxide. J Hematother Stem Cell Res 12 (3): 351-358 (Pubitemid 36736746)
12. Bauwens D, Hantson P, Laterre PF, Michaux L, Latinne D, De Tourtchaninoff M, Cosnard G, Hernalsteen D (2005) Recurrent seizures and sustained encephalopathy associated with dimethylsulfoxide-preserved stem cell infusion. Leuk Lymphoma 46 (11): 1671-1674 (Pubitemid 41701003)
13. Beaujean F, Hartmann O, Kuentz M, Le Forestier C, Divine M, Duedari N (1991) A simple efficient washing procedure for cryopreserved human haemopoietic stem cells prior to infusion. Bone Marrow Transplant 8 (4): 291-294
14. Benekli M, Anderson B, Wentling D, Bernstein S, Czuczman M, McCarthy P (2000) Severe respiratory depression after dimethyl sulphoxide-containing autologous stem cell infusion in a patient with AL amyloidosis. Bone Marrow Transplant 25 (12): 1299-1301 (Pubitemid 30428146)
15. Bojanic I, Cepulic BG, Mazic S, Batinic D, Nemet D, Labar B (2008) Toxicity related to autologous peripheral blood haematopoietic progenitor cell infusion is associated with number of granulocytes in graft, gender and diagnosis of multiple myeloma. Vox Sang 95 (1): 70-75 (Pubitemid 351799418)
16. Bond GR, Curry SC, Dahl DW (1989) Dimethyl sulphoxideinduced encephalopathy. Lancet 1 (8647): 1134-1135
17. Calmels B, Houze P, Hengesse JC, Ducrot T, Malenfant C, Chabannon C (2003) Preclinical evaluation of an automated closed fluid management device: cytomate, for washing out DMSO from hematopoietic stem cell grafts after thawing. Bone Marrow Transplant 31 (9): 823-828 (Pubitemid 36656677)
18. Calmels B, Lemarie C, Esterni B, Malugani C, Charbonnier A, Coso D et al (2007) Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product. Transfusion 47 (7): 1268-1275 (Pubitemid 46934320)
19. Chen-Plotkin AS, Vossel KA, Samuels MA, Chen MH (2007) Encephalopathy, stroke and myocardial infarction with DMSO use in stem cell transplantation. Neurology 68: 859-861 (Pubitemid 46568539)
20. Clark T, Murray JS, Lane P, Politzer P (2008) Why are dimethyl sulfoxide and dimethyl sulfone such good solvents? J Mol Model 14 (8): 689-697
21. Cordoba R, Arrieta R, Kerguelen A, Hernandez-Navarro F (2007) The occurrence of adverse events during the infusion of autologous peripheral blood stem cells is related to the number of granulocytes in the leukapheresis product. Bone Marrow Transplant 40 (11): 1063-1067 (Pubitemid 350142560)
22. Corso S, Vukelja SJ, Wiener D, Baker WJ (1993) Diffuse alveolar hemorrhage following autologous bone marrow infusion. Bone Marrow Transplant 12 (3): 301-303 (Pubitemid 23268168)
23. Curcoy AI, Alcorta I, Estella J, Rives S, Toll T, Tuset E (2002) Cryopreservation of HPCs with high cell concentration in 5% DMSO for transplantation to children. Transfusion 42 (7): 962
24. Darabi K, Brown JR, Kao GS (2005) Paradoxical embolism after peripheral blood stem cell infusion. Bone Marrow Transplant 36 (6): 561-562 (Pubitemid 43118155)
25. Davis JM, Rowley SD, Braine HG, Piantadosi S, Santos GW (1990) Clinical toxicity of cryopreserved bone marrow graft infusion. Blood 75 (3): 781-786 (Pubitemid 20069222)
26. Decot V, Houze P, Stoltz JF, Bensoussan D (2009) Quantification of residual dimethylsulfoxide after washing cryopreserved stem cells and thawing tissue grafts. Biomed Mater Eng 19 (4-5): 293-300
27. Dhodapkar M, Goldberg SL, Tefferi A, Gertz MA (1994) Reversible encephalopathy after cryopreserved peripheral blood stem cell infusion. Am J Hematol 45 (2): 187-188 (Pubitemid 24092590)
28. Directive 2002/98/EC of the European Parliament and the Council of 27th January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC. Official Journal of the European Union, L33/30, 08/02/2003
29. Directive 2004/23/EC of the European Parliament and the Council of 31st March 2004 on setting the standards of quality and safety for the donation procurement, testing, processing, preservation, storage and distribution of human tissues and cells. Official Journal of the European Union, L102/48 07/04/2004
30. Directive 2006/17/EC of 8th February 2006 implementing Directive 2004/23/EC of the European Parliament and of the Council as regards certain technical requirements for donation, procurement and testing of human tissues and cells. Official Journal of the European Union, L38/40 09/02/2006
31. Directive 2006/86/EC of the 24th October 2006 implementing Directive 2004/23/EC of the European Parliament and of the Council as regards traceability requirements, notification of serious adverse reactions and events and certain technical requirements for the coding, processing, preservation, storage and distribution of human tissues and cells. Official Journal of the European Union, L294/32 25/10/2006
32. Donmez A, Tombuloglu M, Gungor A, Soyer N, Saydam G, Cagirgan S (2007) Clinical side effects during peripheral blood progenitor cell infusion. Transfus Apher Sci 36 (1): 95-101 (Pubitemid 46341968)
33. Dorozynski A (1999) Former French ministers on trial over blood. BMJ 318: 76
34. Ferrucci PF, Martinoni A, Cocorocchio E, Civelli M, Cinieri S, Cardinale D, Peccatori F, Lamantia G, Agazzi A, Corsini C, Tealdo F, Fiorentini C, Cipolla C, Fermond J, Arnutt B, Mounier N, Ertant M, Lotz J, Galacier L, Raffoux E, Bentuman N, Marolleau J, Larghero J (2000) Evaluation of acute toxicities associated with autologous peripheral blood progenitor cell reinfusion in patients undergoing high-dose chemotherapy. Bone Marrow Transplant 25 (2): 173-177 (Pubitemid 30087987)
35. Fois E, Desmartin M, Benhamida S, Xavier F, Vanneaux V, Rea D, Fermond J, Arnutt J, Mounier N, Ertant M, Lotz J, Galacier L, Raffoux E, Bentuman N, Marolleau J, Larghero J (2007) Recovery, viability and clinical toxicity of thawed and washed haematopoietic progenitor cells: analysis of 952 autologous peripheral blood stem cell transplantations. Bone Marrow Transplant 40 (9): 831-835 (Pubitemid 350020316)
36. Galmes A, Besalduch J, Bargay J, Novo A, Morey M, Guerra JM et al (1999) Long-term storage at -80°C of hematopoietic progenitor cells with 5% dimethyl sulfoxide as the sole cryoprotectant. Transfusion 39 (1): 70-73 (Pubitemid 29065962)
37. Galmes A, Gutierrez A, Sampol A, Canaro M, Morey M, Iglesias J et al (2007) Long-term hematological reconstitution and clinical evaluation of autologous peripheral blood stem cell transplantation after cryopreservation of cells with 5 and 10% dimethylsulfoxide at -80°C in amechanical freezer. Haematologica 92 (7): 986-989 (Pubitemid 350144248)
38. Golubic B, Bojanic I (2010) Vigilance of stem cell collection and reinfusion in university hospital centre Zagreb: 12th international haemovigilance seminar. Blood Transfus 8 (Suppl 1): 4-5
39. Gomez S, Nagler A, Naparstek E, Slavin S (1991) Transient elevation of serum lactic dehydrogenase following autologous bone marrow transplantation. Bone Marrow Transplant 7 (6): 487-488
40. Guide to the preparation, use and quality assurance of blood components, 15th Edition Council of Europe, (2009). http://www.edqm.eu/en/Blood-transfusion- organ-transplantationguides-1131.html
41. Halle P, Tournilhac O, Knopinska-Posluszny W, Kanold J, Gembara P, Boiret N, Rapatel C, Berger H, Travade P, Augielski S, Bouhomme J, Demeocq F (2001) Uncontrolled-rate freezing and storage at -80°C, with only 3.5% DMSO in cryoprotective solution for 109 autologous peripheral blood progenitor cell transplantations. Transfusion 41 (5): 667-673 (Pubitemid 32845010)
42. Hequet O, Dumontet C, El Jaafari-Corbin A, Salles G, Espinouse D, Arnaud P, Thieblemont C, Bouafia F, Coiffer B (2002) Epileptic seizures after autologous peripheral blood progenitor infusion in a patient treated with highdose chemotherapy for myeloma. Bone Marrow Transplant 29 (6): 544 (Pubitemid 34428730)
43. Higman MA, Port JD, Beauchamp NJ Jr, Chen AR (2000) Reversible leukoencephalopathy associated with re-infusion of DMSO preserved stem cells. Bone Marrow Transplant 26 (7): 797-800
44. Hoyt R, Szer J, Grigg A (2000) Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells. Bone Marrow Transplant 25 (12): 1285-1287 (Pubitemid 30428144)
45. Hunt CJ, Pegg DE, Armitage SE (2006) Optimising cryopreservation protocols for haematopoietic progenitor cells: a methodological approach for umbilical cord blood. Cryo Lett 27 (2): 73-86
46. Junior AM, Arrais CA, Saboya R, Velasques RD, Junqueira PL, Dulley FL (2008) Neurotoxicity associated with dimethylsulfoxide-preserved hematopoietic progenitor cell infusion. Bone Marrow Transplant 41 (1): 95-96
47. Kessinger A, Schmit-Pokorny K, Smith D, Armitage J (1990) Cryopreservation and infusion of autologous peripheral blood stemcells.BoneMarrowTransplant 5 (Suppl 1): 25-27 (Pubitemid 20118147)
48. Keung YK, Lau S, Elkayam U, Chen SC, Douer D (1994) Cardiac arrhythmia after infusion of cryopreserved stem cells. Bone Marrow Transplant 14 (3): 363-367 (Pubitemid 24295226)
49. Koliakos G, Alamdari DH, Tsagias N, Kouzi-Koliakos K, Michaloudi E, Karagiannis V (2007) A novel high-yield volume-reduction method for the cryopreservation of UC blood units. Cytotherapy 9 (7): 654-659 (Pubitemid 47604655)
50. Konuma T, Ooi J, Takahashi S, Tomonari A, Tsukada N, Kobayashi T, Sato A, Kato S, Kasahara S, Elihara Y, Nagamura-Inoue T, Tsuji K, Tojo A, Asano S (2008) Cardiovascular toxicity of cryopreserved cord blood cell infusion. Bone Marrow Transplant 41 (10): 861-865 (Pubitemid 351761688)
51. Lakota J, Fuchsberger P (1996) Autologous stem cell transplantation with stem cells preserved in the presence of 4.5 and 2.2% DMSO. Bone Marrow Transplant 18 (1): 262-263
52. Laroche V, McKenna DH, Moroff G, Schierman T, Kadidlo D, McCullough J (2005) Cell loss and recovery in umbilical cord blood processing: a comparison of post thaw and post wash samples. Transfusion 45 (12): 1909-1916 (Pubitemid 43971417)
53. Lemarie C, Calmels B, Malenfant C, Arneodo V, Blaise D, Viret F et al (2005) Clinical experience with the delivery of thawed and washed autologous blood cells, with an automated closed fluid management device: cytomate. Transfusion 45 (5): 737-742 (Pubitemid 40656387)
54. Liseth K, Abrahamsen JF, Bjorsvik S, Grottebo K, Bruserud O (2005) The viability of cryopreserved PBPC depends on the DMSO concentration and the concentration of nucleated cells in the graft. Cytotherapy 7 (4): 328-333 (Pubitemid 41535837)
55. Lopez-Jimenez J, Cervero C, Murioz A, Hernandez-Madrid A, Fernandez J, Garcia J, Moro C, Maldonado M, Perez J, Otheo E (1994) Cardiovascular toxicities related to the infusion of cryopreserved graft: result of a controlled study. Bone Marrow Transplant 13: 789-793 (Pubitemid 24195797)
56. Madkaikar M, Gupta M, Ghosh K, Swaminathan S, Sonawane L, Mohanty D (2007) Optimising methods of red cell sedimentation from cord blood to maximise nucleated cell recovery prior to cryopreservation. Br J Biomed Sci 64 (4): 157-159
57. Mandanas RA, Kratochvil K, Garner T, Selby GB (1999) Formation of fibrin clots in cryopreserved stem cell bags during thawing procedure: lack of impact on engraftment in autologous stem cell transplantation. Bone Marrow Transplant 23 (3): 303-304 (Pubitemid 29078347)
58. Martino M, Morabito F, Messina G, Irrera G, Pucci G, Iacopino P (1996) Fractionated infusions of cryopreserved stem cells may prevent DMSO-induced major cardiac complications in graft recipients. Haematologica 81 (1): 59-61 (Pubitemid 28020258)
59. Milone G, Mercurio S, Strano A, Leotta S, Pinto V, Battiato K, Coppoletta S, Murgano P, Farsaci B, Privitera A, Giustolisi R (2007) Adverse events after infusions of cryopreserved hematopoietic stem cells depend on nonmononuclear cells in the infused suspension and patient age. Cytotherapy 9 (4): 348-355 (Pubitemid 46993223)
60. Miniero R, Vai S, Giacchino M, Giubellino C, Madon E (1992) Severe respiratory depression after autologous bone marrow infusion. Haematologica 77 (1): 98-99
61. Mueller LP, Theurich S, Christopeit M, Grothe W, Muetherig A, Weber T, Guenther S, Behre G (2007) Neurotoxicity upon infusion of dimethylsulfoxide- cryopreserved peripheral blood stem cells in patients with and without pre-existing cerebral disease. Eur J Haematol 78 (6): 527-531 (Pubitemid 46753597)
62. Okamoto Y, Takaue Y, Saito S, Shimizu T, Suzue T, Abe T, Sato J, Hirao A, Watanabe T, Kawano Y, Kurado Y (1993) Toxicities associated with cryopreserved, thawed peripheral blood stem cell autografts in children with active cancer. Transfusion 33 (7): 578-581 (Pubitemid 23210794)
63. Online document 1. http: //www.eusite.org
64. Online document 3. National classification index: common toxicity criteria http: //ctep.cancer.gov/protocoldevelopment/electronic-applications/ docs/ctcmanual-v4-10-4-99.pdf
65. Online document4.http://ec.europa.eu/health/blood-tissues-organs/docs/ tissues-responses-2008-en.pdf
66. Online document 5. Eurocet registry. http: //www.eurocet.org
67. Online document 6. Substances of human origin project.www.sohovs.org
68. Otrock Z, Beydoun A, Barada WM, Masroujeh R, Hourani R, Bazarbachi A (2008) Transient global amnesia associated with the infusion of DMSO-cryopreserved autologous peripheral blood stem cells. Haematologi 93 (3): 36-37
69. Ozdemir E, Akgedik K, Akdogan S, Kansu E (2008) The lollipop with strawberry aroma may be promising in reduction of infusion-related nausea and vomiting during theinfusion of cryopreserved peripheral blood stem cells. Biol Blood Marrow Transplant 14 (12): 1425-1428
70. Perseghin P, Balduzzi A, Bonanomi S, Dassi M, Buscemi F, Longoni D, Rovelli A, Uderzo C (2000) Infusion-related side-effects in children undergoing autologous hematopoietic stem cell transplantation for acute leukemia. Bone Marrow Transplant 26 (1): 116-118 (Pubitemid 30456121)
71. Petropoulou AD, Bellochine R, Norol F, Marie JP, Rio B (2007) Coronary artery spasm after infusion of cryopreserved cord blood cells. Bone Marrow Transplant 40 (4): 397-398 (Pubitemid 47202428)
72. Rapoport AP, Rowe JM, Packman CH, Ginsberg SJ (1991) Cardiac arrest after autologous marrow infusion. Bone Marrow Transplant 7 (5): 401-403
73. Richter E, Eichler H, Raske D, Leveringhaus A, Zieger W, Kerowgan M et al (1998) Five percent Me2SO is sufficient to preserve stem cells derived from cord blood. Bone Marrow Transplant 22 (Suppl 1): S16 (Pubitemid 28375267)
74. Rosskopf K et al (1999) Clots in cryopreserved peripheral blood stem cell concentrates at time of thawing: possible causes and prophylactic strategies. Bone Marrow Transplant 40: 1063-1067
75. Rowley SD, Anderson GL (1993) Effect of DMSO exposure without cryopreservation on hematopoietic progenitor cells. Bone Marrow Transplant 11 (5): 389-393 (Pubitemid 23162504)
76. Rowley SD, MacLeod B, Heimfeld S, Holmberg L, Besinger W (1999a) Severe central nervous system toxicity associated with the infusion of cryopreserved peripheral blood stem cell components. Cytotherapy 1: 311-317
77. Rowley SD, Feng Z, Yadock D, Holmberg L, MacLeod B, Heimfeld S (1999b) Post-thaw removal of DMSO does not completely abrogate infusion toxicity or the need for preinfusion histamine blockade. Cytotherapy 1 (6): 439-446
78. Ruiz-Delgado G, Mancia-Guerra C, Tamez-Gomez E, Rodrí-guez-Romo LN, López-Otero A, Hernández-Arizpe A, Gómez-Almaguer D, Ruiz-Argüelles GJ (2009) Dimethyl sulfoxide-induced toxicity in cord blood stem cell transplantation: report of three cases and review of the literature. Acta Haematol 122: 1-5
79. Schlegel P, Wolfi M, Schick J, Winkler B, Eyrich M (2009) Transient loss of conscientiousness in pediatric recipients of dimethyl sulfoxide (DMSO)-cryopreserved peripheral blood stem cells independent of morphine co-medication. Haematologica 94 (10): 1473-1475
80. Stroncek DF, Fautsch SK, Lasky LC, Hurd DD, Ramsay NK, McCullough J (1991) Adverse reactions in patients transfused with cryopreserved marrow. Transfusion 31 (6): 521-526
81. Styler M, Topolsky D, Crilley P, Covelsky V, Bryan R, Brodsky I (1992) Transient high grade heart block following autologous bone marrow infusion. Bone Marrow Transplant 10: 435-810
82. Syme R, Bewick M, Stewart D, Porter K, Chadderton T, Gluck S (2004) The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects and toxicity. Biol Blood Marrow Transplant 10 (2): 135-141 (Pubitemid 38145867)
83. Windrum P, Morris TC (2003) Severe neurotoxicity because of dimethyl sulphoxide following peripheral blood stem cell transplantation. Bone Marrow Transplant 31 (4): 315 (Pubitemid 36336239)
84. Windrum P, Morris TC, Drake MB, Niederwieser D, Ruutu T (2005) Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres. Bone Marrow Transplant 36 (7): 601-603 (Pubitemid 43115015)
85. Yellowlees P, Greenfield C, McIntyre N (1980) Dimethylsulphoxide-induced toxicity. Lancet 2 (8202): 1004-1006 (Pubitemid 10025073)
86. Zambelli A, Poggi G, Da PG, Pedrazzoli P, Cuomo A, Miotti Det al (1998) Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res 18 (6B): 4705-4708 (Pubitemid 29042047)
87. Zenhausern R, Tobler A, Leoncini L, Hess OM, Ferrari P (2000) Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in apatient with severe primary cardiac amyloidosis and endstage renal failure. Ann Hematol 79 (9): 523-526